openPR Logo
Press release

Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth

04-03-2018 02:15 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Diabetes Drugs Market: Increasing Prevalence of Diabetes

According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025.

Research and Development Pursuits to Introduce Novel Products Stokes Growth

The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food habits has been one of the key factors behind the high prevalence of obesity, which accounts as a major cause for diabetes. Sedentary lifestyle leading to rise in the prevalence of diabetes has surged the demand for diabetes drugs. The increasing prevalence of diabetes in developing as well as developed countries is driving the diabetes drugs market. Rising disposable incomes leading to high consumption of high calories food combined with inclination for physical inactivity are some other key factors behind the high prevalence of diabetes, thus boosting the growth of diabetes drugs market. Increasing geriatric population globally and increasing adoption of therapeutics for type 1 and type 2 diabetes are anticipated to boost the diabetes drugs market.

View Report Preview at https://globenewswire.com/news-release/2018/01/16/1289694/0/en/Diabetes-Drugs-Market-is-expanding-at-a-CAGR-of-3-6-by-2025-globally-Transparency-Market-Research.html

Research and development for introduction of improved drugs is also acting in favor of the growth of diabetes drugs market. For example, in 2017, Novo Nordisk A/S launched Xultophy in the U.S. as an alternative to diet and exercise to improve glycemic level among patients of type 2 diabetes. According to World Health Organization, currently 422 million people suffer from diabetes globally, which is leading to a surging demand for diabetes drugs.

Among the key types of diabetes, Type 2 diabetes accounts for the leading market share due to its higher prevalence. Growing pace of obesity among urban populace, rising disposable income, and increasing awareness of therapeutics for diabetes are likely to have a positive impact on this segment. Out of the various segments based on distribution channel, hospital pharmacies currently hold the leading market share due to presence of trained staff to dispense medicines. The segment of online pharmacies is also likely to display remarkable growth due to growth of e-commerce and rising number of online shoppers. Geography-wise, North America is anticipated to lead the global market due to high awareness regarding therapeutics for diabetes and a robust public healthcare system.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14672

Patent Expiration of Blockbuster Drugs Hampers Growth

On the flip side, patent expiration of blockbuster drugs may restrain the demand for branded drugs during the forecast period. In addition, poor regulatory framework to monitor the dispensing of these drugs is also restraining the market’s growth. Poor rate of awareness regarding diabetes management is also hampering the market’s growth.

Transparency Market Research (TMR), in one of its latest reports states the global diabetes drugs market to be fragmented and intensely competitive due to the presence of several key vendors. With the expansion of product portfolio of existing companies and entry of new players, the competition in the market is likely to intensify in the future. Geographical expansion by means of mergers and acquisitions and strategic alliances continue to remain another key growth strategy for players in the market.

Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14672

The report identifies Novartis AG, Boehringer Ingelheim GmbH, Sanofi, Novo Nordisk A/S, Merck & Co., and Bayer AG as leading players in the global diabetes drugs market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth here

News-ID: 1001865 • Views: 261

More Releases from Transparency Market Research

Gene Delivery System Market is estimated to attain a valuation of US$ 4,281.0 Mn …
The global Gene Delivery System Market is estimated to attain a valuation of US$ 4,281.0 Mn by the end of 2025, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.8% during the forecast period, 2017 to 2026. The key objective of the TMR report is to offer a complete assessment of the global market including major
Ophthalmology Surgical Devices Market is estimated to attain a valuation of US$ …
The global Ophthalmology Surgical Devices Market is estimated to attain a valuation of US$ 11.0 Bn by the end of 2025, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4% during the forecast period, 2017 to 2026. The key objective of the TMR report is to offer a complete assessment of the global market including major
Hyperhidrosis Treatment Market and is Projected to Expand to 2027
Transparency Market Research (TMR) has published a new report on the global hyperhidrosis treatment market for the forecast period of 2019-2027. According to the report, the global hyperhidrosis treatment market was valued at ~US$ 1.2 Bn in 2018, and is projected to expand at a CAGR of ~4% from 2019 to 2027. The global market is driven by increase in awareness and acceptance of hyperhidrosis treatment due to the launch of
Mica Market Know Market Dynamics, Opportunities and Risks
𝐌𝐢𝐜𝐚 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 Transparency Market Research delivers key insights on the global mica market. In terms of revenue, the global mica market is estimated to expand at a CAGR of 2.90% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global mica market. 𝐑𝐞𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 - https://www.transparencymarketresearch.com/mica-market.html The global mica market is broadly affected by several factors including increase in

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.